Novabay Pharmaceuticals (NBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 1,054 | 3,477 | 6,947 | 11,019 | 9,754 |
| Cost of Goods | 486 | 162 | 8 | 0 | N/A |
| Gross Profit | 568 | 3,315 | 6,939 | 11,019 | 9,754 |
| Operating Expenses | 17,958 | 18,963 | 15,256 | 15,340 | 14,270 |
| Operating Income | -16,904 | -15,486 | -8,309 | -4,321 | -4,516 |
| Other Income | 1,712 | -554 | 1,284 | -762 | 258 |
| Pre-tax Income | -15,192 | -16,040 | -7,025 | -5,083 | -4,258 |
| Income Tax | 2 | 2 | 2 | -2 | 50 |
| Net Income Continuous | -15,194 | -16,042 | -7,027 | -5,081 | -4,308 |
| Net Income | $-15,194 | $-16,042 | $-7,027 | $-5,081 | $-4,308 |
| EPS Basic Total Ops | -9,352.54 | -12,849.04 | -7,335.32 | -6,112.77 | -5,501.49 |
| EPS Basic Continuous Ops | -9,357.93 | -12,843.62 | -7,293.27 | -6,025.49 | -5,644.73 |
| EPS Diluted Total Ops | -9,352.54 | -12,849.04 | -7,335.32 | -6,112.77 | -5,501.49 |
| EPS Diluted Continuous Ops | -9,357.93 | -12,843.62 | -7,293.27 | -6,025.49 | -5,644.73 |
| EBITDA(a) | $-16,672 | $-15,172 | $-7,968 | $-3,896 | $-4,079 |